IN BRIEF: Seed Innovations notes investment by portfolio firm Avextra

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Seed Innovations Ltd - investment firm focused on early-stage health, wellness and medical cannabis companies - Notes announcement by portfolio company Avextra AG, a German medical cannabis company, in which Seed holds a 3% stake.

Avextra enters a strategic, long-term partnership with the Instituto Universitario de Ciencias da Saude-Cooperativa de Ensino Superior Politecnico e Universitario, focused on research and development of regulator-approved medicines based on the cannabis plant. Avextra will invest up to €15 million over five years, with the potential for even greater investment in R&D depending on the research results.

Current stock price: 2.00 pence

12-month change: down 15%

Copyright 2023 Alliance News Ltd. All Rights Reserved.